Atlas Trials

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Clinical trial NCT04542356 · COMPLETED

Trial details

NCT number
NCT04542356
Sponsor
Chongqing University Cancer Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2018-08-01
Primary completion
2021-01-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.